FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to infectious diseases and hepatology, and can be used for prediction of metabolic syndrome development in chronic viral hepatitis C in the absence of antiviral therapy. That is ensured by determining a body weight index and concentration of the following blood values in a patient with chronic hepatitis C: alanine aminotransferase, low-density lipoproteins, immunoreactive insulin, total thyroxine. That is followed by calculating the value of the discriminant function by formula, after which the nomogram is used to define the percentage of the probability of developing metabolic syndrome in the patients with chronic hepatitis C 5–10 years after the antiviral therapy.
EFFECT: invention provides more accurate prediction of the probability of developing metabolic syndrome in the patients with chronic hepatitis C in 5–10 years with no antiviral therapy.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF LIPID DISTRESS SYNDROME DEVELOPMENT IN PATIENTS WITH STABLE VIROLOGIC RESPONSE TO ANTIVIRAL THERAPY OF CHRONIC HEPATITIS C | 2019 |
|
RU2710264C1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF ANTIVIRAL THERAPY OF CHRONIC HEPATITIS B | 2011 |
|
RU2469327C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF LIPID DISTRESS SYNDROME IN CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2710254C1 |
| METHOD FOR PREDICTION OF A STABLE VIROLOGIC RESPONSE TO THERAPY OF CHRONIC HEPATITIS C WITH PREPARATIONS OF DIRECT ANTIVIRAL ACTION IN THE PRESENCE OF LIPID DISTRESS SYNDROME | 2019 |
|
RU2710257C1 |
| METHOD FOR PREDICTION OF ANTIRETROVIRAL THERAPY OUTCOMES IN CHRONIC HEPATITIS B | 2014 |
|
RU2571493C2 |
| METHOD OF PERSONIFIED PREDICTION OF CLINICAL EFFECTIVENESS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME | 2020 |
|
RU2737503C1 |
| METHOD FOR VERIFYING CHRONIC HEPATIC PATHOLOGY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2013 |
|
RU2547246C1 |
| METHOD FOR METABOLIC SYNDROME PREDICTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2633931C1 |
| METHOD OF PREDICTING RISK OF PROGRESSION OF BRONCHIAL OBSTRUCTION IN PATIENTS WITH COMORBID CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METABOLIC SYNDROME | 2023 |
|
RU2812296C1 |
| METHOD OF PREDICTING BY BIOCHEMICAL PARAMETRES CHRONIC HEPATITIS C TREATMENT OUTCOME AFTER THREE MONTHS SINCE BEGINNING OF ANTIVIRAL THERAPY | 2009 |
|
RU2408283C1 |
